Akorn News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.08.22	Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg (PR Newswire)
21.05.20	Akorn Files For Bankruptcy (RTTNews)
01.04.20	Akorn Sale Process Impacted By Market Uncertainties - Quick Facts (RTTNews)
10.02.20	Akorn Continues To Evaluate Strategic Alternatives - Quick Facts (RTTNews)
31.10.19	Akorn Updates 2019 Net Loss Guidance - Quick Facts (RTTNews)
01.08.19	Akorn Widens FY19 Loss Outlook, But Affirms Revenue Forecast - Quick Facts (RTTNews)
07.05.19	Akorn Q1 Loss Widens; But Stock Surges (RTTNews)
10.01.19	5 Top Losers In Healthcare Sector (RHE, MBOT, AKRX...) (RTTNews)
09.01.19	Akorn Gets FDA Warning Letter On Decatur, Illinois Manufacturing Facility (RTTNews)
21.12.18	FDA Nod For GNMK, AKRX Gets New CEO, PTI Plunges After-hours (RTTNews)
06.11.18	Akorn Inc Q3 adjusted earnings of -$0.06 per share (RTTNews)
18.10.18	Has Akorn Put The Worst Behind It? (RTTNews)
10.10.18	Akorn Reports ANDA Approval For Bimatoprost Ophthalmic Solution - Quick Facts (RTTNews)
02.10.18	AKRX Slumps On Court Ruling, OMER Reports IgA Data, INSM On Watch (RTTNews)
01.10.18	Akorn To Appeal Court Ruling In Complaint Against Fresenius Kabi - Quick Facts (RTTNews)
24.08.18	PAVM Plunges On FDA News, AKRX Awaits D-Day, LCI Keeps Hitting New Lows (RTTNews)
29.05.18	Moore Kuehn, PLLC Announces an Investigation Involving Possible Breaches of Fiduciary Duties by Officers and Directors of Akorn, Inc. (PR Newswire)
24.04.18	Lifshitz & Miller LLP Announces Investigation of Acadia Healthcare Company, Inc., Akorn, Inc., Blackhawk Network Holdings, Inc., Facebook, Inc., IZEA Inc., MuleSoft, Inc., Solid Biosciences Inc. (PR Newswire)
23.04.18	Akorn Asks Court To Require Fresenius To Fulfill Obligations Under Merger Deal (RTTNews)
23.04.18	BHVN In Focus, Fresenius Calls Off Deal To Buy AKRX, Good News For GUD (RTTNews)
23.04.18	Fresenius Terminates $4.3 Bln Akorn Takeover; Akorn Says Enforce Its Rights (RTTNews)
12.04.18	AKORN ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc. - AKRX (PR Newswire)
11.04.18	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX (PR Newswire)
03.04.18	AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc. To Contact The Firm (PR Newswire)
27.03.18	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: May 7, 2018 (PR Newswire)
09.03.18	Block & Leviton LLP Announces The Filing Of A Class Action Against Akorn, Inc. (AKRX) (PR Newswire)
01.03.18	AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Akorn, Inc. To Contact The Firm (PR Newswire)
28.02.18	AKRX In The Cross Hairs, NSPR Slumps On Stock Offering, AKCA On Watch (RTTNews)
27.02.18	Akorn Remains Sharply Lower After Initial Sell-Off (RTTNews)
27.02.18	Investor Alert: Kaplan Fox Announces Investigation Of Akorn, Inc. (PR Newswire)
27.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX) (PR Newswire)
27.02.18	Akorn Provides Statement On Investigation (RTTNews)
26.02.18	Fresenius SE 2017 Profit Rises; Organic Sales Growth At 6% - Quick Facts (RTTNews)
09.02.18	AKRX Investor Alert: Kyros Law is Filing Compensation Claims on Behalf of Akorn Pharmaceuticals (NASDAQ: AKRX) Investors (PR Newswire)
18.01.18	Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a... (PR Newswire)
04.01.18	Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a... (PR Newswire)
08.07.17	Johnson & Weaver, Announces Investigations of Omega Protein Corporation, Monogram Residential Trust, Inc. and Akorn, Inc.; Investors Encouraged to Contact Firm (PR Newswire)
06.07.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: August 21, 2017 (PR Newswire)
29.06.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX) (PR Newswire)
28.06.17	Generic Drugs Stocks on Investors' Radar -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharma (PR Newswire)
23.05.17	Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Akorn, Inc. - AKRX (PR Newswire)
17.05.17	Financial Professionals Applaud Expanded Access to Data as Informa Financial Intelligence's Zephyr Analytics® API Celebrates First Birthday (PR Newswire)
15.05.17	How These Generic Drugs Stocks are Faring? -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy (PR Newswire)
29.04.17	Lifshitz & Miller LLP Announces Investigation of AdvancePierre Foods Holdings, Inc., Akorn, Inc., AllianceMMA, Inc., Altisource Portfolio Solutions, DelTaco Restaurants, Inc., Express Scripts... (PR Newswire)
26.04.17	AKORN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akorn, Inc. (PR Newswire)
25.04.17	Harwood Feffer LLP Announces Investigation of Akorn, Inc. (PR Newswire)
25.04.17	AKORN (AKRX) ALERT: J&W Launches Investigation into the Sale of Akorn; Is $34 a Fair Price? (PR Newswire)
24.04.17	Fresenius Kabi To Buy Akorn; To Acquire Merck KGaA's Biosimilars Business (RTTNews)
10.04.17	AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN (RTTNews)
08.04.17	Germany's Fresenius Confirms Talks To Buy Generic Drugmaker Akorn (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

26.02.19		Ausblick: Akorn legt Zahlen zum jüngsten Quartal vor
01.10.18		Fresenius-Aktie wird von Gerichtsentscheid angetrieben: Fresenius muss Akorn nicht übernehmen
23.04.18		Medizinkonzern Fresenius bläst milliardenschwere Übernahme von Akorn ab
27.02.18		Fresenius-Chef schliesst Rückzug bei Übernahme von Akorn nicht aus
20.07.17		Akorn-Aktionäre stimmen Übernahme durch Fresenius Kabi zu
25.04.17		Fresenius Kabi übernimmt Akorn und Merck-Biosimilars-Geschäft

26.02.19

Ausblick: Akorn legt Zahlen zum jüngsten Quartal vor

01.10.18

Fresenius-Aktie wird von Gerichtsentscheid angetrieben: Fresenius muss Akorn nicht übernehmen

23.04.18

Medizinkonzern Fresenius bläst milliardenschwere Übernahme von Akorn ab

27.02.18

Fresenius-Chef schliesst Rückzug bei Übernahme von Akorn nicht aus

20.07.17

Akorn-Aktionäre stimmen Übernahme durch Fresenius Kabi zu

25.04.17

Fresenius Kabi übernimmt Akorn und Merck-Biosimilars-Geschäft